Interleukin 13-mediated colitis in the absence of IL-4Rα signalling

Jennifer C Hoving; Antony J Cutler; Mosiuoa Leeto; William G C Horsnell; Benjamin G Dewals; Natalie E Nieuwenhuizen; Frank Brombacher

doi:10.1136/gutjnl-2016-313208

Interleukin 13-mediated colitis in the absence of IL-4Rα signalling

Gut. 2017 Nov;66(11):2037-2039. doi: 10.1136/gutjnl-2016-313208. Epub 2017 Feb 28.

Authors

Jennifer C Hoving^{1

2}, Antony J Cutler^{1

2

3}, Mosiuoa Leeto^{1

2}, William G C Horsnell^{1

2}, Benjamin G Dewals^{1

2

4}, Natalie E Nieuwenhuizen^{1

2

5}, Frank Brombacher^{1

2}

Affiliations

¹ International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, Cape Town, South Africa.
² Division of Immunology, Institute of Infectious Diseases and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town and South African Medical Research Council (SAMRC), Cape Town, South Africa.
³ JDRF/Wellcome Trust Diabetes and Inflammation Laboratory, Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, UK.
⁴ Fundamental and Applied Research in Animals and Health, Faculty of Veterinary Medicine, University of Liege, Belgium.
⁵ Department of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany.

PMID: 28246312
DOI: 10.1136/gutjnl-2016-313208

No abstract available

Keywords: CYTOKINES; IMMUNE RESPONSE; INTERLEUKINS; ULCERATIVE COLITIS.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Colitis*
Colitis, Ulcerative
Humans
Interleukin-13*
Interleukins

Substances

Interleukin-13
Interleukins